Influences of Multivitamin Supplementation on Health Parameters
- Conditions
- Health Behavior
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: multivitamin supplement
- Registration Number
- NCT03071796
- Lead Sponsor
- Martin-Luther-Universität Halle-Wittenberg
- Brief Summary
In this study the investigator will evaluate whether a liquid multivitamin supplement influences blood and vital parameters. Furthermore the investigator will establish the effects on life quality, mood and perception of stress and will characterize changes on immune system.
- Detailed Description
The double-blind, randomized intervention study is conducted for 12 weeks and includes two groups (placebo versus verum) with same number of participants.
The investigator aims to determine the effects of multivitamin supplement on blood and vital parameters which includes blood pressure, pulse, heart rate, variability of heart rate, vitamin D, vitamin B12, folic acid, homocysteine, HbA1c. Furthermore the investigator will access life quality, mood and perception of stress through the following questionnaire POMS, PSS-10, SF12 \& SF36. The investigator will evaluate whether the multivitamin supplement changes the frequency of diseases like cold which represents the function of the immune system.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 80
- healthy women and men
- age between 30-60 years
- employed
- acute and chronic diseases (including diabetes, inflammatory bowel diseases, dementia, multiple sclerosis)
- frequent use of alcohol, drugs or cigarettes (>5 cigarettes / day)
- use of additional supplements
- use of medications (e.g. antihypertensive medications, lipid reducers, thyroid medication)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description placebo Placebo liquids with similar appearance and taste like multivitamin supplement for 12 weeks multivitamin supplement multivitamin supplement liquid multivitamin supplement for 12 weeks
- Primary Outcome Measures
Name Time Method Plasma concentration of Vitamin B12 change measures (baseline to 12 weeks) vitamin B12 \[pmol/l\]
- Secondary Outcome Measures
Name Time Method Analysis of blood pressure change measures (baseline to 12 weeks) blood pressure
Analysis of heart rate variability change measures (baseline to 12 weeks) heart rate variability
Analysis of speed of pulse wave, change measures (baseline to 12 weeks) speed of pulse wave
Plasma concentration of 25-hydroxyvitamin D change measures (baseline to 12 weeks) 25-hydroxyvitamin D \[nmol/l\]
Plasma concentration of folic acid change measures (baseline to 12 weeks) folic acid \[nmol/l\]
Plasma concentration of homocysteine change measures (baseline to 12 weeks) homocysteine \[µmol/l\]
Plasma concentration of HbA1c change measures (baseline to 12 weeks) HbA1c \[mmol\]
Trial Locations
- Locations (1)
University of Halle-Wittenberg
🇩🇪Halle (Saale), Germany